Rondol is a privately owned DeepTech company that provides optimum dosing machinery and continuous manufacturing solutions to Pharma and BioTech for improved treatment efficiency and lower capital intensity. This year, we will present our research at AAPS 2022 in Boston, both on Antimalarials with BASF and Queens University Belfast, and on Aspirin with SEQENS and Institut Jean Lamour.
• The exceptional precision of mixing provided by twin screw extrusion allows to anticipate and tackle the toxicity of some APIs for which the dose needed to be effective could create unnecessary secondary effects.
• The vertical continuous manufacturing process is faster and of lower cost than conventional tableting/compression technology that involves numerous steps usually occurring in different parts of the manufacturing plant, at different sites, or even in different countries.